Project Scope

To understand prevalence, unmet need, value drivers of current treatment, and expected factors driving the use of pipeline treatments for wet Age-related Macular Degeneration (AMD) in KSA

Challenge

Our client is a manufacturer of ophthalmology products designed for the treatment of eye disorders such as wet and dry AMD. They sought to investigate the satisfaction levels associated with existing treatments while also aiming to gain insights into the future evolution of these treatments and assess how new therapies fit into various therapeutic categories. Additionally, the client aimed to compare different therapeutic categories to determine the preferred choice of therapy

Solution

Conducted primary market research to get detailed insights on:

• Unmet needs for wet AMD
• Current treatment landscape
• Perception on future treatments and different therapeutic classes
• Expectations from new therapies

Results

Successfully enabled our client to understand:

• Current disease prevalence, unmet needs, treatment landscape and future treatment landscape
• Physicians expectations from current and future therapies
• Key drivers of success and the factors that influence the adoption of gene therapies for wet AMD